評論
打印
According to UPI, a combination of chemotherapy and antibody medication
UPI消息稱在一項新試驗中，將化學療法和抗體藥物相結合
extended the lives of people with triple-negative breast cancer by up to 10 months in a new trial.
能延長三陰性乳腺癌患者的壽命長達10個月。
Researchers led by Queen Mary University of London and St. Bartholomew's Hospital found
倫敦大學瑪麗皇后學院和圣巴塞洛繆醫院的研究人員發現
that the combination helped the body's immune system turn back the aggressive type of breast cancer.
兩種療法相結合可以幫助身體免疫系統阻擋攻擊性乳腺癌。
The method also reduced the risk of death or the cancer progressing by up to 40 percent,
這種方法還可以減少死亡風險，或是減少癌癥擴散進程40%，
according to the study published Saturday in New England Journal of Medicine and
該研究于周六發表于《新英格蘭醫學期刊》并
presented at the European Society for Medical Oncology 2018 Congress in Munich, Germany.
在德國慕尼黑歐洲臨床腫瘤學會2018年會議上提出。
譯文屬可可英語原創，未經允許，不得轉載。
